- Home
- CMPX vs SHMD Comparison
CMPX vs SHMD Comparison
Compare CMPX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SHMD
- Stock Information
- Founded
- CMPX 2014
- SHMD 1864
- Country
- CMPX United States
- SHMD Germany
- Employees
- CMPX N/A
- SHMD N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SHMD
- Sector
- CMPX Health Care
- SHMD
- Exchange
- CMPX Nasdaq
- SHMD Nasdaq
- Market Cap
- CMPX 291.8M
- SHMD 123.6M
- IPO Year
- CMPX N/A
- SHMD N/A
- Fundamental
- Price
- CMPX $2.60
- SHMD $2.77
- Analyst Decision
- CMPX Strong Buy
- SHMD
- Analyst Count
- CMPX 8
- SHMD 0
- Target Price
- CMPX $13.13
- SHMD N/A
- AVG Volume (30 Days)
- CMPX 955.2K
- SHMD 24.1K
- Earning Date
- CMPX 08-11-2025
- SHMD 02-25-2025
- Dividend Yield
- CMPX N/A
- SHMD N/A
- EPS Growth
- CMPX N/A
- SHMD N/A
- EPS
- CMPX N/A
- SHMD N/A
- Revenue
- CMPX $850,000.00
- SHMD $85,165,542.00
- Revenue This Year
- CMPX N/A
- SHMD N/A
- Revenue Next Year
- CMPX N/A
- SHMD N/A
- P/E Ratio
- CMPX N/A
- SHMD N/A
- Revenue Growth
- CMPX N/A
- SHMD N/A
- 52 Week Low
- CMPX $0.77
- SHMD $1.86
- 52 Week High
- CMPX $4.08
- SHMD $5.17
- Technical
- Relative Strength Index (RSI)
- CMPX 62.59
- SHMD N/A
- Support Level
- CMPX $2.52
- SHMD N/A
- Resistance Level
- CMPX $2.71
- SHMD N/A
- Average True Range (ATR)
- CMPX 0.17
- SHMD 0.00
- MACD
- CMPX 0.01
- SHMD 0.00
- Stochastic Oscillator
- CMPX 72.88
- SHMD 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).